Unresolved disorder model. using A ATOM 172 CA AILE 22 27.619 5.817 24.881 0.44 11.46 C Unresolved disorder model. using A ATOM 173 CA BILE 22 27.608 5.825 24.857 0.56 11.70 C Unresolved disorder model. using A ATOM 176 CB AILE 22 26.626 6.909 24.451 0.44 12.64 C Unresolved disorder model. using A ATOM 177 CB BILE 22 26.596 6.884 24.373 0.56 12.03 C Unresolved disorder model. using A ATOM 178 CG1AILE 22 25.675 7.417 25.537 0.44 12.89 C Unresolved disorder model. using A ATOM 179 CG1BILE 22 25.432 7.121 25.339 0.56 13.14 C Unresolved disorder model. using A ATOM 180 CG2AILE 22 25.811 6.434 23.247 0.44 14.53 C Unresolved disorder model. using A ATOM 181 CG2BILE 22 26.098 6.525 22.976 0.56 13.17 C Unresolved disorder model. using A ATOM 182 CD1AILE 22 26.309 7.888 26.821 0.44 17.21 C Unresolved disorder model. using A ATOM 183 CD1BILE 22 24.547 8.314 25.090 0.56 14.70 C Unresolved disorder model. using A ATOM 392 CA ASER 50 -3.875 8.863 17.208 0.49 16.99 C Unresolved disorder model. using A ATOM 393 CA BSER 50 -3.905 8.825 17.196 0.51 16.70 C Unresolved disorder model. using A ATOM 396 CB ASER 50 -4.096 10.267 17.782 0.49 21.32 C Unresolved disorder model. using A ATOM 397 CB BSER 50 -4.254 10.197 17.780 0.51 21.93 C Unresolved disorder model. using A ATOM 398 OG ASER 50 -4.737 10.212 19.041 0.49 24.13 O Unresolved disorder model. using A ATOM 399 OG BSER 50 -5.036 10.959 16.872 0.51 26.89 O Unresolved disorder model. using A ATOM 813 CA AGLN 103 15.506 -14.330 16.164 0.54 7.67 C Unresolved disorder model. using A ATOM 814 CA BGLN 103 15.553 -14.351 16.107 0.46 8.07 C Unresolved disorder model. using A ATOM 817 CB AGLN 103 16.998 -14.597 16.227 0.54 9.77 C Unresolved disorder model. using A ATOM 818 CB BGLN 103 17.042 -14.642 15.949 0.46 9.67 C Unresolved disorder model. using A ATOM 819 CG AGLN 103 17.634 -14.989 14.917 0.54 11.85 C Unresolved disorder model. using A ATOM 820 CG BGLN 103 17.435 -14.759 14.481 0.46 10.61 C Unresolved disorder model. using A ATOM 821 CD AGLN 103 19.108 -15.334 15.073 0.54 14.32 C Unresolved disorder model. using A ATOM 822 CD BGLN 103 18.810 -15.381 14.336 0.46 14.12 C Unresolved disorder model. using A ATOM 823 OE1AGLN 103 19.553 -15.922 16.068 0.54 20.75 O Unresolved disorder model. using A ATOM 824 OE1BGLN 103 18.968 -16.547 14.710 0.46 20.20 O Unresolved disorder model. using A ATOM 825 NE2AGLN 103 19.882 -14.989 14.058 0.54 13.71 N Unresolved disorder model. using A ATOM 826 NE2BGLN 103 19.785 -14.655 13.833 0.46 17.32 N Unresolved disorder model. using A ATOM 1288 CA AASP 164 10.716 -5.255 -4.750 0.67 21.39 C Unresolved disorder model. using A ATOM 1289 CA BASP 164 10.967 -5.316 -4.635 0.33 20.21 C Unresolved disorder model. using A ATOM 1292 CB AASP 164 9.564 -5.649 -5.709 0.67 28.72 C Unresolved disorder model. using A ATOM 1293 CB BASP 164 10.203 -6.277 -5.538 0.33 25.03 C Unresolved disorder model. using A ATOM 1294 CG AASP 164 9.007 -7.018 -5.422 0.67 29.45 C Unresolved disorder model. using A ATOM 1295 CG BASP 164 10.404 -7.750 -5.271 0.33 27.56 C Unresolved disorder model. using A ATOM 1296 OD1AASP 164 9.730 -7.774 -4.730 0.67 40.28 O Unresolved disorder model. using A ATOM 1297 OD1BASP 164 11.421 -8.180 -4.693 0.33 27.30 O Unresolved disorder model. using A ATOM 1298 OD2AASP 164 7.880 -7.326 -5.863 0.67 41.87 O Unresolved disorder model. using A ATOM 1299 OD2BASP 164 9.496 -8.531 -5.660 0.33 28.70 O Chain identifier should be blank not A: ATOM 2066 ZN ZN A 506 14.511 0.445 15.435 1.00 31.44 ZN 1